Skip to content
10-Q

Quarterly Report

NewGen BioPharma Corp.

0001640334-17-000450

← back to feed
Filed
Mar 9, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Mar 6, 2017 22.6M sh
Stockholders Equity Q1 2017 · Jan 31, 2017 −$28.65K
Stockholders Equity Q1 2017 · Oct 31, 2016 −$125.18K
Total Liabilities Q1 2017 · Jan 31, 2017 $230K
Total Liabilities Q1 2017 · Oct 31, 2016 $125.18K
Current Assets Q1 2017 · Jan 31, 2017 $201.36K
Total Assets Q1 2017 · Jan 31, 2017 $201.36K
Sga Expense Q1 2017 · Jan 31, 2017 $3.86K
Sga Expense Q1 2017 · Jan 31, 2016 $1.2K
Net Income Q1 2017 · Jan 31, 2017 −$153.47K
Net Income Q1 2017 · Jan 31, 2016 −$11.29K
Operating Income Q1 2017 · Jan 31, 2017 −$154.83K
Operating Income Q1 2017 · Jan 31, 2016 −$11.29K